These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37918852)

  • 1. Increased expression of CXCL6 in secretory cells drives fibroblast collagen synthesis and is associated with increased mortality in idiopathic pulmonary fibrosis.
    Bahudhanapati H; Tan J; Apel RM; Seeliger B; Schupp J; Li X; Sullivan DI; Sembrat J; Rojas M; Tabib T; Valenzi E; Lafyatis R; Mitash N; Hernandez Pineda R; Jawale C; Peroumal D; Biswas P; Tedrow J; Adams T; Kaminski N; Wuyts WA; McDyer JF; Gibson KF; Alder JK; Königshoff M; Zhang Y; Nouraie M; Prasse A; Kass DJ
    Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 37918852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model.
    Besnard AG; Struyf S; Guabiraba R; Fauconnier L; Rouxel N; Proost P; Uyttenhove C; Van Snick J; Couillin I; Ryffel B
    J Leukoc Biol; 2013 Dec; 94(6):1317-23. PubMed ID: 23975892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis.
    Zhao T; Wu X; Zhao X; Yao K; Li X; Ni J
    Front Immunol; 2023; 14():1159856. PubMed ID: 37122736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-nucleus chromatin accessibility identifies a critical role for TWIST1 in idiopathic pulmonary fibrosis myofibroblast activity.
    Valenzi E; Bahudhanapati H; Tan J; Tabib T; Sullivan DI; Nouraie M; Sembrat J; Fan L; Chen K; Liu S; Rojas M; Lafargue A; Felsher DW; Tran PT; Kass DJ; Lafyatis R
    Eur Respir J; 2023 Jul; 62(1):. PubMed ID: 37142338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
    Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
    Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
    Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
    [No Abstract]   [Full Text] [Related]  

  • 7. PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state.
    Caporarello N; Meridew JA; Jones DL; Tan Q; Haak AJ; Choi KM; Manlove LJ; Prakash YS; Tschumperlin DJ; Ligresti G
    Thorax; 2019 Aug; 74(8):749-760. PubMed ID: 31182654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury.
    Kass DJ; Yu G; Loh KS; Savir A; Borczuk A; Kahloon R; Juan-Guardela B; Deiuliis G; Tedrow J; Choi J; Richards T; Kaminski N; Greenberg SM
    Am J Pathol; 2012 May; 180(5):1963-78. PubMed ID: 22429962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical advance: The use of tree shrews as a model of pulmonary fibrosis.
    Larson-Casey JL; He C; Che P; Wang M; Cai G; Kim YI; El Hamdaoui M; Grytz R; Ding Q; Carter AB
    PLoS One; 2020; 15(11):e0241323. PubMed ID: 33141839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality.
    Tsitoura E; Trachalaki A; Vasarmidi E; Mastrodemou S; Margaritopoulos GA; Kokosi M; Fanidis D; Galaris A; Aidinis V; Renzoni E; Tzanakis N; Wells AU; Antoniou KM
    Front Immunol; 2021; 12():645548. PubMed ID: 34867934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL6 in idiopathic pulmonary fibrosis: a novel mediator in the complex epithelial-mesenchymal crosstalk.
    Helou DG; Crestani B
    Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 38176704
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular Distribution of Secreted Phospholipase A2 in Lungs of IPF Patients and Its Inhibition in Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Jaiswal A; Rehman R; Dutta J; Singh S; Ray A; Shridhar M; Jaisankar J; Bhatt M; Khandelwal D; Sahoo B; Ram A; Mabalirajan U
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.
    Mackinnon AC; Gibbons MA; Farnworth SL; Leffler H; Nilsson UJ; Delaine T; Simpson AJ; Forbes SJ; Hirani N; Gauldie J; Sethi T
    Am J Respir Crit Care Med; 2012 Mar; 185(5):537-46. PubMed ID: 22095546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis.
    Philp CJ; Siebeke I; Clements D; Miller S; Habgood A; John AE; Navaratnam V; Hubbard RB; Jenkins G; Johnson SR
    Am J Respir Cell Mol Biol; 2018 May; 58(5):594-603. PubMed ID: 29053339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R-Spondin-2 Is Upregulated in Idiopathic Pulmonary Fibrosis and Affects Fibroblast Behavior.
    Munguía-Reyes A; Balderas-Martínez YI; Becerril C; Checa M; Ramírez R; Ortiz B; Meléndez-Zajgla J; Pardo A; Selman M
    Am J Respir Cell Mol Biol; 2018 Jul; 59(1):65-76. PubMed ID: 29345973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis.
    MacKenzie B; Korfei M; Henneke I; Sibinska Z; Tian X; Hezel S; Dilai S; Wasnick R; Schneider B; Wilhelm J; El Agha E; Klepetko W; Seeger W; Schermuly R; Günther A; Bellusci S
    Respir Res; 2015 Jul; 16(1):83. PubMed ID: 26138239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis.
    Kurowska-Stolarska M; Hasoo MK; Welsh DJ; Stewart L; McIntyre D; Morton BE; Johnstone S; Miller AM; Asquith DL; Millar NL; Millar AB; Feghali-Bostwick CA; Hirani N; Crick PJ; Wang Y; Griffiths WJ; McInnes IB; McSharry C
    J Allergy Clin Immunol; 2017 Jun; 139(6):1946-1956. PubMed ID: 27746237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.